EV Biologics (EV Biologics) LT-Debt-to-Total-Asset : 0.00 (As of Dec. 2017)

View and export this data going back to 2015. Start your Free Trial

What is EV Biologics LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. EV Biologics's long-term debt to total assests ratio for the quarter that ended in Dec. 2017 was 0.00.

EV Biologics's long-term debt to total assets ratio declined from Jun. 2016 (0.00) to Dec. 2017 (0.00). It may suggest that EV Biologics is progressively becoming less dependent on debt to grow their business.

EV Biologics LT-Debt-to-Total-Asset Historical Data

The historical data trend for EV Biologics's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EV Biologics LT-Debt-to-Total-Asset Chart

EV Biologics Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

LT-Debt-to-Total-Asset

0.01

EV Biologics Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17	Dec17
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial												-	-	-	-	-

EV Biologics LT-Debt-to-Total-Asset Calculation

EV Biologics's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2017 is calculated as

LT Debt to Total Assets (A: Jun. 2017 )	=	Long-Term Debt & Capital Lease Obligation (A: Jun. 2017 )	/	Total Assets (A: Jun. 2017 )
	=	0	/	33.278
	=	0.00

EV Biologics's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2017 is calculated as

LT Debt to Total Assets (Q: Dec. 2017 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2017 )	/	Total Assets (Q: Dec. 2017 )
	=	0	/	58.954
	=	0.00

EV Biologics (OTCPK:YECO) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

EV Biologics LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of EV Biologics's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

EV Biologics (EV Biologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EV Biologics Inc (OTCPK:YECO) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

XCNQ:NIRV ENVB BLCM NLSP BRTX ADTX XKRX:066830 ALLR XMAD:ADL ARTL

Traded in Other Exchanges

N/A

Address

1621 Central Avenue, Cheyenne, WY, USA, 82001

Website

https://www.evbiologics.com

EV Biologics Inc is developing the extraordinary biological properties of extracellular vesicles (EVs) to create the next generation of diagnostic modalities and safe, effective biotherapeutics to improve outcomes of serious clinical conditions, increase natural longevity and transform lives.

Executives

Daniel S Mckinney	director, 10 percent owner, officer: CEO	TWO IFC, 19TH FLOOR, 8 FINANCE STREET, CENTRAL, HONG KONG F4 000000
Michael W Harlan	director	C/O WASTE CONNECTIONS, INC., 610 APPLEWOOD CRESCENT, SUITE 200, VAUGHAN A6 L4K 0C3